Real-world time to discontinuation of first-li... - CLL Support
Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
You need to be a member of this community to see this post.
Read more about...
7 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Encouraging results from venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
second venetoclax treatment, from a trial of 46 CLL patients who relapsed after their initial...
Zanubrutinib, Obinutuzumab and Venetoclax. Front line Clinical Trial.
usually low for me.
In a month I start Cycle 3 in which Venetoclax is introduced via a five week...
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Update on The CLARITY Study
CLARITY Study in UK.
CLARITY is a phase II trial that combined ibrutinib with venetoclax in...
Small lymphocytic lymphoma (SLL)
of CLL and SLL and found a great article by the late Professor Hamblin, further reviewed by CLL...
Chronic lymphocytic leukemia
know if I ned to start treatment or wait till I have symptoms
The treatment has no chemotherapy in...
Chronic lymphocytic leukemia
Son diagnosed with Chronic Lymphocytic Leukemia
Obinutuzumab & Venetoclax - tired & weak all the time
